Payment overview · 2025
General Payments
$248.33
5 reported records · 3 companies
Healthcare provider profile · identity verified
Srinivasa M. Murthy, M.D.
Allopathic & Osteopathic Physicians|Family Medicine · OCALA, FL · NPI 1922034388
Verified facts
What the public records show
CMS Open Payments records show Srinivasa M. Murthy, M.D. received $248.33 in general payments during 2025 across 5 reported records.
Stryker Corporation accounted for 69.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 4 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Ozempic.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 40 claims for Ozempic by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Stryker Corporation | Unresolved — no canonical attribution shown | $171.37 | 69.0% | 1 | 2025 |
| Otsuka America Pharmaceutical, Inc. | Unresolved — no canonical attribution shown | $45.17 | 18.2% | 2 | 2025 |
| Novo Nordisk Inc | Unresolved — no canonical attribution shown | $31.79 | 12.8% | 2 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $248.33 | 5 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| MAKO Normalized: mako |
Device | Stryker Corporation | $171.37 | 1 | 2025 |
Source payment records
|
|||||
| REXULTI Normalized: rexulti |
Drug | Otsuka America Pharmaceutical, Inc. | $45.17 | 2 | 2025 |
Source payment records
|
|||||
| Wegovy Normalized: wegovy |
Drug | Novo Nordisk Inc | $16.92 | 1 | 2025 |
Source payment records
|
|||||
| Ozempic Normalized: ozempic |
Drug | Novo Nordisk Inc | $14.87 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| Ozempic ozempic |
2025 | Ozempic | 2024 | 40 Beneficiary count suppressed |
exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Ozempic open payments reported associated product |
CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076 |
Ozempic · 2024 Exact normalized brand match · 1 Part D row |
40 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 974 | 271 |
| Amlodipine Besylate | Amlodipine Besylate | 676 | 178 |
| Levothyroxine Sodium | Levothyroxine Sodium | 481 | 117 |
| Lisinopril | Lisinopril | 464 | 115 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 425 | 117 |
| Gabapentin | Gabapentin | 409 | 85 |
| Metformin Hcl | Metformin Hcl | 361 | 101 |
| Losartan Potassium | Losartan Potassium | 350 | 99 |
| Omeprazole | Omeprazole | 311 | 83 |
| Metoprolol Tartrate | Metoprolol Tartrate | 284 | 78 |
| Furosemide | Furosemide | 279 | 61 |
| Tamsulosin Hcl | Tamsulosin Hcl | 247 | 54 |
| Eliquis | Apixaban | 226 | 36 |
| Trazodone Hcl | Trazodone Hcl | 208 | 43 |
| Potassium Chloride | Potassium Chloride | 194 | 35 |
| Sertraline Hcl | Sertraline Hcl | 181 | 42 |
| Carvedilol | Carvedilol | 172 | 42 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 170 | 51 |
| Glimepiride | Glimepiride | 167 | 48 |
| Pantoprazole Sodium | Pantoprazole Sodium | 162 | 50 |
| Metoprolol Succinate | Metoprolol Succinate | 155 | 38 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 147 | 27 |
| Hydrochlorothiazide | Hydrochlorothiazide | 139 | 37 |
| Levetiracetam | Levetiracetam | 136 | 17 |
| Simvastatin | Simvastatin | 134 | 36 |
| Famotidine | Famotidine | 126 | 27 |
| Allopurinol | Allopurinol | 118 | 27 |
| Clopidogrel | Clopidogrel Bisulfate | 118 | 30 |
| Azithromycin | Azithromycin | 109 | 87 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 104 | 70 |
| Finasteride | Finasteride | 103 | 23 |
| Mirtazapine | Mirtazapine | 100 | 24 |
| Baclofen | Baclofen | 99 | 13 |
| Clonidine Hcl | Clonidine Hcl | 99 | 35 |
| Donepezil Hcl | Donepezil Hcl | 99 | 26 |
| Alendronate Sodium | Alendronate Sodium | 96 | 27 |
| Januvia | Sitagliptin Phosphate | 95 | 15 |
| Divalproex Sodium | Divalproex Sodium | 89 | 13 |
| Citalopram Hbr | Citalopram Hydrobromide | 87 | 21 |
| Xarelto | Rivaroxaban | 86 | 13 |
| Atenolol | Atenolol | 82 | 20 |
| Glipizide | Glipizide | 79 | 18 |
| Mounjaro | Tirzepatide | 79 | 14 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 75 | 12 |
| Escitalopram Oxalate | Escitalopram Oxalate | 74 | 20 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 71 | 13 |
| Montelukast Sodium | Montelukast Sodium | 71 | 20 |
| Duloxetine Hcl | Duloxetine Hcl | 68 | 20 |
| Memantine Hcl | Memantine Hcl | 67 | 14 |
| Ondansetron Hcl | Ondansetron Hcl | 65 | 27 |
| Buspirone Hcl | Buspirone Hcl | 62 | 17 |
| Alprazolam | Alprazolam | 61 | 18 |
| Warfarin Sodium | Warfarin Sodium | 57 | suppressed |
| Cephalexin | Cephalexin | 56 | 43 |
| Synthroid | Levothyroxine Sodium | 56 | 14 |
| Tramadol Hcl | Tramadol Hcl | 55 | 17 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 54 | suppressed |
| Entresto | Sacubitril/Valsartan | 53 | suppressed |
| Meloxicam | Meloxicam | 52 | 12 |
| Quetiapine Fumarate | Quetiapine Fumarate | 52 | 13 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 52 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 51 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 50 | 14 |
| Amoxicillin | Amoxicillin | 49 | 40 |
| Clonazepam | Clonazepam | 49 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 49 | 13 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 48 | 16 |
| Valsartan | Valsartan | 47 | 16 |
| Lorazepam | Lorazepam | 45 | suppressed |
| Prednisone | Prednisone | 45 | 20 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 44 | 21 |
| Cefaclor | Cefaclor | 43 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 43 | suppressed |
| Spironolactone | Spironolactone | 43 | 15 |
| Diclofenac Sodium | Diclofenac Sodium | 42 | suppressed |
| Nystatin | Nystatin | 42 | 19 |
| Bumetanide | Bumetanide | 41 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 40 | suppressed |
| Lactulose | Lactulose | 40 | suppressed |
| Ozempic | Semaglutide | 40 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 38 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 38 | 14 |
| Pravastatin Sodium | Pravastatin Sodium | 37 | 11 |
| Propranolol Hcl | Propranolol Hcl | 37 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 36 | 16 |
| Hydralazine Hcl | Hydralazine Hcl | 36 | 11 |
| Lamotrigine | Lamotrigine | 36 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 36 | suppressed |
| Methylprednisolone | Methylprednisolone | 35 | 31 |
| Zolpidem Tartrate | Zolpidem Tartrate | 34 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 32 | suppressed |
| Latanoprost | Latanoprost | 31 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 30 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 30 | suppressed |
| Risperidone | Risperidone | 30 | suppressed |
| Ezetimibe | Ezetimibe | 28 | suppressed |
| Fenofibrate | Fenofibrate | 27 | suppressed |
| Humulin R | Insulin Regular, Human | 27 | suppressed |
| Sildenafil Citrate | Sildenafil Citrate | 26 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 26 | suppressed |
| Chlorthalidone | Chlorthalidone | 25 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 25 | suppressed |
| Gemfibrozil | Gemfibrozil | 25 | suppressed |
| Ketoconazole | Ketoconazole | 25 | suppressed |
| Prednisolone Acetate | Prednisolone Acetate | 25 | suppressed |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 25 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 24 | suppressed |
| Breyna | Budesonide/Formoterol Fumarate | 24 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 24 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 24 | suppressed |
| Linzess | Linaclotide | 24 | suppressed |
| Tradjenta | Linagliptin | 24 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 23 | suppressed |
| Novolin 70-30 Flexpen | Insulin Nph Hum/Reg Insulin Hm | 23 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 23 | suppressed |
| Carbamazepine | Carbamazepine | 22 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 22 | 13 |
| Levemir Flexpen | Insulin Detemir | 22 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 21 | suppressed |
| Jardiance | Empagliflozin | 21 | suppressed |
| Sotalol | Sotalol Hcl | 21 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 19 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 19 | suppressed |
| Celecoxib | Celecoxib | 19 | suppressed |
| Digoxin | Digoxin | 19 | suppressed |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 19 | suppressed |
| Metolazone | Metolazone | 19 | suppressed |
| Nifedipine Er | Nifedipine | 19 | suppressed |
| Novolog Flexpen | Insulin Aspart | 19 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 18 | 13 |
| Bupropion Hcl | Bupropion Hcl | 18 | suppressed |
| Fluconazole | Fluconazole | 18 | 13 |
| Hydrocortisone | Hydrocortisone | 18 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 18 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 18 | suppressed |
| Pregabalin | Pregabalin | 18 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 18 | suppressed |
| Estradiol | Estradiol | 17 | suppressed |
| Levofloxacin | Levofloxacin | 17 | 13 |
| Medroxyprogesterone Acetate | Medroxyprogesterone Acetate | 17 | suppressed |
| Nitroglycerin | Nitroglycerin | 17 | 11 |
| Nystatin-Triamcinolone | Nystatin/Triamcinolone Acet | 17 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 17 | suppressed |
| Aripiprazole | Aripiprazole | 16 | suppressed |
| Bupropion Xl | Bupropion Hcl | 16 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 16 | suppressed |
| Methimazole | Methimazole | 16 | suppressed |
| Methotrexate | Methotrexate Sodium | 16 | suppressed |
| Myrbetriq | Mirabegron | 16 | suppressed |
| Silver Sulfadiazine | Silver Sulfadiazine | 16 | suppressed |
| Trulicity | Dulaglutide | 16 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 16 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 15 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 15 | 11 |
| Metronidazole | Metronidazole | 15 | suppressed |
| Naproxen | Naproxen | 15 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 15 | suppressed |
| Olanzapine | Olanzapine | 15 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 14 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 14 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 14 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 14 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 14 | suppressed |
| Mupirocin | Mupirocin | 14 | 11 |
| Risedronate Sodium | Risedronate Sodium | 14 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 13 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 13 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 13 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 13 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 13 | suppressed |
| Junel Fe | Norethindrone-E.Estradiol-Iron | 13 | suppressed |
| Lacosamide | Lacosamide | 13 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 13 | suppressed |
| Methocarbamol | Methocarbamol | 13 | suppressed |
| Primidone | Primidone | 13 | suppressed |
| Torsemide | Torsemide | 13 | suppressed |
| Aspirin-Dipyridamole Er | Aspirin/Dipyridamole | 12 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 12 | suppressed |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 12 | suppressed |
| Gentamicin Sulfate | Gentamicin Sulfate | 12 | suppressed |
| Humira(Cf) Pen | Adalimumab | 12 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 12 | suppressed |
| Lansoprazole | Lansoprazole | 12 | suppressed |
| Lidocaine | Lidocaine | 12 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 12 | suppressed |
| Mometasone Furoate | Mometasone Furoate | 12 | suppressed |
| Neomycin-Polymyxin-Dexameth | Neomycin/Polymyxin B/Dexametha | 12 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 12 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 12 | suppressed |
| Silodosin | Silodosin | 12 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 12 | suppressed |
| Tamoxifen Citrate | Tamoxifen Citrate | 12 | suppressed |
| Brilinta | Ticagrelor | 11 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 11 | suppressed |
| Fiasp Flextouch | Insulin Aspart (Niacinamide) | 11 | suppressed |
| Indomethacin | Indomethacin | 11 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 11 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 11 | suppressed |
| Temazepam | Temazepam | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $248.33 · 5 records | Stryker Corporation | MAKO, Ozempic, REXULTI, Wegovy | 1 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Ozempic play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with Novo Nordisk Inc?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error